NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 46 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $136,482 | +30.8% | 92,000 | +12.2% | 0.00% | – |
| Q2 2023 | $104,345 | +12.7% | 82,000 | +18.8% | 0.00% | – |
| Q1 2023 | $92,564 | -55.2% | 69,000 | -47.3% | 0.00% | – |
| Q4 2022 | $206,522 | -6.6% | 131,000 | -26.0% | 0.00% | – |
| Q4 2021 | $221,000 | -49.1% | 177,000 | -45.9% | 0.00% | – |
| Q3 2021 | $434,000 | +1396.6% | 327,000 | +1386.4% | 0.00% | – |
| Q2 2021 | $29,000 | +3.6% | 22,000 | +4.8% | 0.00% | – |
| Q1 2021 | $28,000 | -75.2% | 21,000 | -74.4% | 0.00% | – |
| Q4 2020 | $113,000 | +175.6% | 82,000 | +173.3% | 0.00% | – |
| Q3 2020 | $41,000 | +24.2% | 30,000 | +50.0% | 0.00% | – |
| Q2 2020 | $33,000 | +22.2% | 20,000 | -4.8% | 0.00% | – |
| Q1 2020 | $27,000 | -15.6% | 21,000 | 0.0% | 0.00% | – |
| Q4 2019 | $32,000 | -87.3% | 21,000 | -88.6% | 0.00% | – |
| Q3 2019 | $252,000 | -78.0% | 184,000 | -80.8% | 0.00% | -100.0% |
| Q4 2018 | $1,144,000 | – | 958,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| III Capital Management | 12,500,000 | $17,262,000 | 3.12% |
| CSS LLC/IL | 24,395,000 | $33,616,000 | 1.59% |
| Mint Tower Capital Management B.V. | 9,000,000 | $12,407,000 | 1.46% |
| Context Partners Fund, L.P. | 3,000,000 | $4,125,000 | 0.90% |
| Context Capital Management, LLC | 3,000,000 | $4,125,000 | 0.90% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,258,000 | $5,971,000 | 0.71% |
| SSI INVESTMENT MANAGEMENT LLC | 5,888,000 | $8,100,000 | 0.70% |
| Aequim Alternative Investments LP | 3,000,000 | $4,155,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,181,000 | $44,437,000 | 0.40% |
| TWO SIGMA SECURITIES, LLC | 13,000,000 | $17,875,000 | 0.36% |